Amgen Inc. buy UBS Group AG
Start price
26.01.26
/
50%
€293.05
Target price
26.01.27
-
Performance (%)
30.13%
Price
21.08.26
€376.30
Summary
This prediction is currently active. With a performance of 30.13% the BUY prediction by UBS_Group_AG is a big success. A total of €5.04 was paid as dividends for this prediction. This prediction currently runs until 26.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 4.834% | 4.834% |
| iShares Core DAX® | -1.283% | 4.209% |
| iShares Nasdaq 100 | -3.338% | -1.744% |
| iShares Nikkei 225® | -4.286% | -1.621% |
| iShares S&P 500 | -2.311% | -0.096% |
Comments by UBS_Group_AG for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for AMGN provided by MarketBeat